Genotoxicity Assessment of HM10620 Containing Recombinant Human Interferon-α

REFERENCES

• Davis G. L., Balart L. A., Schiff E. R., Lindsay K., Bodenheimer H. C. J., Perrillo R. P., Carey W., Jacobson I. M., Payne J., Dienstag J. L. Treatment of chronic hepatitis C with recombinant interferon-α. A multicenter randomized, controlled trial. Hepatitis Interventional Therapy Group. N. Engl. J. Med 1989; 321: 1501–1506
   PubMed Web of Science ®Google Scholar
• Dean B. J., Danford N. Assays for the detection of chemically-induced chromosome damage in cultured mammalian cells. Mutagenicity Testing — A Practical Approach, S. Venitt, J. M. Parry. IRL Press Limited, Oxford 1984; 187–232
   Google Scholar
• Galloway S. M. Cytoxicity and chromosome aberrations in vitro: experience in industry and the case for an upper limit on toxicity in the aberration assay. Environ. Mol. Mutagen 2000; 35: 191–201
   PubMed Web of Science ®Google Scholar
• Georgian L., Ghyka G., Geormaneanu C. A. C., Moraru I. The effect of human alpha interferon on sister chromatid exchange frequency in PHA stimulated lymphocytes from normal donors and from Down's syndrome patients. Rev. Roumaine Biochim 1989; 26: 119–123
   Google Scholar
• Hayashi M., MacGregor J. T., Gatehouse D. G. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing and automated scoring. Environ. Mol. Mutagen 2000; 35: 234–252
   PubMed Web of Science ®Google Scholar
• Heddle J. A., Stuart E., Salamone M. F. The bone marrow micronucleus test. Handbook of Mutagenicity Test Procedures2nd, B. J. Kilbey, M. Legator, W. Nichols, C. Ramel. Elsevier Science Publishers BV, Amsterdam 1984; 441–457
   Google Scholar
• Henderson L., Cole R., Cole J., Cole H., Aghamohammdi Z., Regan T. Sister-chromatid exchange and micronucleus induction as indicators of genetic damage in maternal and foetal cells. Mutat. Res 1984; 126: 47–52
   PubMed Web of Science ®Google Scholar
• Hild F., Freund M., Fonatsch C. Chromosomal aberrations during interferon therapy for chronic myelogenous leukaemia. New Engl. J. Med 1991; 325: 132
   PubMed Web of Science ®Google Scholar
• Ishidate M. J., Sofuni T., Yoshikawa K. Chromosomal aberration tests in vitro as a primary screening tool for environmental mutagens and/or carcinogens. GANN Monogr. Cancer Res 1981; 27: 95–107
   Google Scholar
• Kochhar T. S. Steroid enhanced sister-chromatid exchange in cultured CHO cells. Experientia 1988; 44: 62–63
   PubMedGoogle Scholar
• Koyama H., Utakoji T., Ono T. A new cell line derived from newborn Chinese hamster lung tissue. GANN 1970; 61: 161–167
   PubMedGoogle Scholar
• Krishna G., Hayashi M. In vivo rodent micronucleus assay: protocol, conduct and data interpretation. Mutat. Res 2000; 455: 155–166
   PubMed Web of Science ®Google Scholar
• Lovell D. P., Anderson D., Albanese R., Amphlett G. E., Clare G., Ferguson R., Richold M., Papworth D. G., Savage J. R. K. Statistical analysis on in vivo cytogenetic assays. Statistical Evaluation of Mutagenicity Test Data, D. J. Kirkland. Cambridge University Press, Cambridge 1989; 184–232
   Google Scholar
• Maron D. M., Ames B. N. Revised methods for the Salmonella mutagenicity test. Mutat. Res 1983; 113: 173–215
   PubMed Web of Science ®Google Scholar
• Mertens R., Severin K., Habedank M. Effect of human recombinant IFN-α and IFN-I3 on the sister-chromatid exchange (SCE) frequency in amniotic fluid ceils in vitro. Mutat. Res 1993; 300: 195–200
   PubMed Web of Science ®Google Scholar
• Muller L., Sofuni T. Appropriate levels of cytoxicity for genotoxicity tests using mammalian cells in vitro. Environ. Mol. Mutagen 2000; 35: 202–205
   PubMed Web of Science ®Google Scholar
• Osborn B. L., Olsen H. S., Nardelli B., Murray J. H., Zhou J. X. H., Garcia A., Moody G., Zaritskaya L.S., Cynthia Sung C. Pharmacokinetic and pharmacodynamic studies of a human serum albumin-interferon-fusion protein in cynomolgus monkeys. J. Pharmacol. Exp. Ther 2002; 303: 540–548
   PubMed Web of Science ®Google Scholar
• Richardson C., Williams D. A., Allen J. A., Amphlett G., Chanter D. O., Phillips B. Analysis of data from in vitro cytogenetics assays. Statistical Evaluation of Mutagenicity Test Data, D. J. Kirkland. Cambridge University Press, Cambridge 1989; 141–154
   Google Scholar
• Rios A., Mansell P. W., Newell G. R., Reuben J. M., Hersh E. M., Gutterman J. U. Treatment of acquired immunodeficiency syndrome–related Kaposi's sarcoma with lymphoblastoid interferon. J. Clin. Oncol 1985; 3: 506–512
   PubMed Web of Science ®Google Scholar
• Sada E., Katoh S., Yamanaka K., Itakura Y. Resistance to proteolysis of antibody ligands modified with polyethylene glycol. J. Ferm. Bioeng 1991; 71: 137–139
   Google Scholar
• Salamone M. F., Heddle J. A. The bone marrow micronucleus assay: rationale for a revised protocol. Chemical Mutagens: Principles and Methods for Their Detection, F. J. de Serres. Plenum Press, New York 1983; 8: 111–149
   Google Scholar
• Schmid W. The micronucleus test. Mutat. Res 1975; 31: 1–9
   Google Scholar
• Sorensen P. J., Jensen M. K., Jersild C. Effects of human leukocyte interferon on human lymphocytes in vitro: cytogenetic studies. Mutat. Res 1981; 90: 143–147
   PubMed Web of Science ®Google Scholar
• Stanton G. J., Langford M. P., Weigent D. A. Cell types involved in production of interferon by leukocytes. Tex. Rep. Biol. Med 1981; 41: 84–88
   PubMedGoogle Scholar
• Tedeschi B., Spadoni G. L., Sanna M. L., Vernole P., Caporossi D., Cianfarani S., Nicoletti B., Boscherini B. Increased chromosome fragility in lymphocytes of short normal children treated with recombinant human growth hormone. Hum. Genet 1993; 91: 459–463
   PubMed Web of Science ®Google Scholar
• Tinwell H., Ashby J. Comparison of acridine orange and Giemsa stains in several mouse bone marrow micronucleus assays – including a triple dose study. Mutagenesis 1989; 4: 476–481
   PubMed Web of Science ®Google Scholar
• Torti F. M., Shortliffe L. D., Williams R. D., Pitts W. C., Kempson R. L., Ross J. C., Palmer J., Meyers F., Ferrari M., Hannigan J. Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study. J. Clin. Oncol 1988; 6: 476–483
   PubMed Web of Science ®Google Scholar
• Vijayalaxmi. Human leukocyte interferon does not induce sister-chromatid exchanges in human blood lymphocytes. Mutat. Res 1982; 105: 287–290
   PubMed Web of Science ®Google Scholar
• Vugrin D., Hood L., Taylor W., Laszlo J. Phase II study of human lymphoblastoid interferon in patients with advanced renal carcinoma. Cancer Treat. Rep 1985; 69: 817–820
   PubMedGoogle Scholar